12:00 AM
 | 
Feb 12, 2007
 |  BioCentury  |  Finance

Almost a billion

Almost a billion

Almost a billion
Last week, the biotech industry raised $907.8 million. Of the publicly traded companies that disclosed share price, only one - Synta - ended the week below its offering price. That may not be surprising for companies that sold private placements - which are usually priced at a discount - but it’s less common for follow-ons. In the IPO space, since last fall,...

Read the full 342 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >